RxMM Health, Inc.
The following information summarizes the status of the individual Companies within the group and their current stages of readiness to utilize significant capital to accelerate the businesses to high growth and profitability.
The following information features a strong emphasis on a unique and strategically structured multi-billion-dollar investment opportunity created by the resurgence of the Hemp industry.
The Companies business strategy is a “Farm-to-Pharma” business acquisition model which includes:
- Cultivation and extraction (hemp & cannabis)
- New product formulations (OTC and prescription)
- Medically approved delivery devices
- Health & wellness treatment & dispensary centres
City Farm Industries, Inc. – Group 1
Potential Valuation in 2019 - $45 Billion
City Farm Industries is a cultivation enterprise focused on exponential growth opportunities for hemp cultivation to meet the burgeoning demand for plant and derivative materials in global markets.
Clerisy Corporation – Group 2
Potential Valuation in 2019 - $37.6 Million
Clerisy Corporation specializes in technology acquisition, manufacture and marketing of FDA approved, leading edge medical delivery devices and proprietary medicinal product formulations.
RxMM Health Capital, Inc. – Group 3
Potential Valuation in 2019 - $4.6 Billion
RxMM Health is a fully integrated seed to sale cannabis cultivator, manufacturer and distributor of cannabis extracts, finished products and cannabis extraction systems.
Revyve Healthcare – Group 4
Potential Valuation in 2019 - $186 Million
Revyve Healthcare is establishing brand leadership in the evolving medicinal cannabis markets for its range of integrated health and wellness products and services.
AgTech Global, Inc. – Group 5
Potential Valuation in 2019 - $149 Million
AgTech Global is an agricultural technology and supply company specializing in advanced organic fertilizers, nutrients and pesticides and hydroponic technology and systems.